⌘K
Loading ticker…
Dyne Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Dyne Therapeutics, Inc. Common Stock (DYN) has a 3-month relative strength percentile of 62 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.2%, relative volume 2.81×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
62 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
DYN is in a stage 2 uptrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 13.7% / 17.3%.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
DYN is held by 8 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $84M notional. Top 3 carry $206M.
Top 8 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $84M |
| XBIState Street SPDR S&P Biotech ETF | 0.84% | $62M |
| IWMiShares Russell 2000 ETF | 0.08% | $59M |
| VBVanguard Small Cap ETF | 0.02% | $31M |
| VXFVanguard Extended Market ETF | 0.04% | $29M |
| VBRVanguard Small Cap Value ETF | 0.03% | $20M |
| IWOiShares Russell 2000 Growth ETF | 0.05% | $6M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $4M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DYN Jan avg: 9.67% median: 8.72% win: 50% σ: 43.41% n: 4 2022-04-12 → 2026-05-29 | DYN Feb avg: -0.77% median: -8.04% win: 25% σ: 18.04% n: 4 2022-04-12 → 2026-05-29 | DYN Mar avg: -3.02% median: -2.51% win: 50% σ: 17.32% n: 4 2022-04-12 → 2026-05-29 | DYN Apr avg: -5.41% median: -10.07% win: 20% σ: 11.06% n: 5 2022-04-12 → 2026-05-29 | DYN May avg: 4.72% median: 10.14% win: 80% σ: 26.97% n: 5 2022-04-12 → 2026-05-29 | DYN Jun avg: 4.87% median: -1.48% win: 50% σ: 28.62% n: 4 2022-04-12 → 2026-05-29 (current) | DYN Jul avg: 21.50% median: 14.93% win: 100% σ: 22.16% n: 4 2022-04-12 → 2026-05-29 | DYN Aug avg: 7.85% median: 0.50% win: 50% σ: 20.48% n: 4 2022-04-12 → 2026-05-29 | DYN Sep avg: -5.03% median: -13.81% win: 25% σ: 24.21% n: 4 2022-04-12 → 2026-05-29 | DYN Oct avg: 6.82% median: -14.95% win: 25% σ: 48.03% n: 4 2022-04-12 → 2026-05-29 | DYN Nov avg: 15.71% median: 4.35% win: 75% σ: 27.89% n: 4 2022-04-12 → 2026-05-29 | DYN Dec avg: -3.65% median: -5.81% win: 25% σ: 18.20% n: 4 2022-04-12 → 2026-05-29 |